Pharma’s Digital IQ: Measuring the Digital Competence of Pharma Brands
A conversation with Scott Hagedorn (PHD Network CEO) and Scott Galloway (L2 founder and NYU Professor of Brand Strategy) about the L2 Digital IQ Index for pharmaceutical brands, a first-of-its kind measurement of the digital competence of 51 pharma brands across eight therapeutic categories.
Is “Social Media” a Distinction Without Meaning in Today’s World? The Role of Social...
Learn how you can decrease time to market and reduce costs to deploy strategic initiatives
Challenges of Regulating Mobile Medical Apps: Legal and Regulatory Issues You Should Know About
A conversation with Joseph Kim, MD, MPH, VP of Medical Affairs and Technology at Medical Communications Media, Inc., about the rapid development of mobile medical applications and the legal and regulatory issues that physicians, patients, and pharma developers/sponsors should be aware of.
Beyond Compliance: Strategic Implications of the Physician Payments Sunshine Act
A conversation with Bill Cooney, President & CEO, Medpoint and Vince DeChellis, Head, NHHS Healthcare Consulting, LLC, about the looming challenge of complying with the Physician Payments
Pharma Wikipedians: The Pros and Cons of Pharma Employees Editing Wikipedia Articles
A conversation with Bertalan Meskó, MD, founder and managing director of Webicina.com, Michael Spitz, SVP and Managing Director at Zemoga, and Silja Chouquet, owner and CEO of whydot GmbH, about a proposal by Dr. Meskó that urged pharmaceutical companies to appoint employees as Wikipedia 'spokespeople' who would perform all Wikipedia article edits on behalf of the company.
Pharma’s Legal Assault Against Off Label Speech Restrictions
A discussion with Darshan Kulkarni, Principal Attorney at the Kulkarni Law Firm, about recent court cases involving pharma's right to speak to physicians about off-label uses of approved drugs.
Patient Power and Pharma: The Role of Patient Advocates in Pharma Marketing
A conversation with Andrew Schorr, Founder and Host of PatientPower.info, about
UCB’s Active Social Media Listening Approach: Better Communications, Better Patient Experiences, & Better Solutions
A conversation with Trish Nettleship, Director, Social Media & Influence, UCB, Inc., about her company's approach to social media and patient centricity, which involves active listening to understand patient needs and issues -- including adverse events -- and how this results in better communications and patient experiences.
Evaluating Rx & OTC DTC TV Ads: Few Are Outright False But Many May...
A conversation with Adrienne E. Faerber, PhD, and David H. Kreling, PhD, talk about the results of their recently published study on the content analysis of claims made in TV direct-to-consumer (DTC) OTC and Rx drug ads.
Evaluating Rx & OTC DTC TV Ads: Few Are Outright False But Many May...
A conversation with Adrienne E. Faerber, PhD, and David H. Kreling, PhD, talk about the results of their recently published study on the content analysis of claims made in TV direct-to-consumer (DTC) OTC and Rx drug ads.
